Health
Lilly’s weight-loss drug expected to show heart benefit similar to Wegovy, experts say
Some leading obesity specialists in the US say they expect Eli Lilly’s potent weight-loss drug Zepbound to produce the same or similar cardiac benefits as
The US FDA has approved Vivos Therapeutics for the treatment of sleep apnoea
Vivos Therapeutics said Wednesday that U.S. health regulators have cleared the use of its oral device to treat severe obstructive sleep apnea, sending the company’s
UK expands HIV screening programme
Singer Elton John addressed British lawmakers as the government announced plans to expand an HIV testing programme as part of its goal to end new
US life expectancy rises after COVID withdrawal
US babies born in 2022 gained about a year in life expectancy compared with those born a year earlier, federal data showed, an improvement after
Suspected counterfeit Ozempic caused hypoglycaemia in 11 people in Lebanon
Eleven people in Lebanon have experienced bouts of dangerously low blood sugar this year, one of whom required hospitalisation after being injected with an allegedly
The US FDA is investigating the safety risks of CAR-T cancer treatment
The US Food and Drug Administration said it is investigating cancer treatments developed by Gilead Sciences, Johnson & Johnson, Novartis and others because of the
BioMarin values a gene therapy for haemophilia in Germany at almost €29,000 per vial
BioMarin Pharmaceutical said the price for the drug to treat severe haemophilia A will be 28,933.53 euros ($31,725.62) per vial for insurers covering most of
Idaho is asking the U.S. Supreme Court to allow a near-total ban on abortion
Idaho officials on Monday asked the U.S. Supreme Court to temporarily halt a federal judge’s ruling that blocked the Republican-run state from enforcing a near-total
Novartis raises sales growth target to 5% per year until 2027
Novartis raised its sales growth target to 5% a year to 2027, citing demand for innovative medicines following the spin-off of its generics business. The
Moderna begins work on an mRNA production site in China
US vaccine maker Moderna began constructing its first plant in China to produce mRNA-based drugs this month, the company said on Tuesday.